Pacer Advisors, Inc. Mirum Pharmaceuticals, Inc. Transaction History
Pacer Advisors, Inc.
- $39 Billion
- Q2 2024
A detailed history of Pacer Advisors, Inc. transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Pacer Advisors, Inc. holds 392 shares of MIRM stock, worth $15,288. This represents 0.0% of its overall portfolio holdings.
Number of Shares
392
Previous 1,240
68.39%
Holding current value
$15,288
Previous $31,000
58.06%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding MIRM
# of Institutions
172Shares Held
54.2MCall Options Held
96.1KPut Options Held
54.8K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.5MShares$253 Million13.09% of portfolio
-
Janus Henderson Group PLC London, X04.99MShares$195 Million0.09% of portfolio
-
Bvf Inc San Francisco, CA4.37MShares$170 Million4.57% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.61MShares$141 Million2.18% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$126 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.43B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...